Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Oral xanthine derivatives (theophylline and doxofylline) for patients with stable chronic obstructive pulmonary disease (COPD)

Información

DOI:
https://doi.org/10.1002/14651858.CD012748Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 03 agosto 2017see what's new
Tipo:
  1. Intervention
Etapa:
  1. Protocol
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Vías respiratorias

Copyright:
  1. Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Olga M García Morales

    Correspondencia a: Department of Internal Medicine, Faculty of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia

    [email protected]

    [email protected]

    Pulmonary Unit, Department of Internal Medicine, Hospital Universitario San Ignacio, Bogotá, Colombia

  • Maria Ximena Rojas‐Reyes

    Department of Clinical Epidemiology and Biostatistics, Faculty of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia

  • Rodolfo J Dennis

    Department of Clinical Epidemiology and Biostatistics, Faculty of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia

    Research Department, Fundacion Cardioinfantil Instituto de Cardiologia, Bogotá, Colombia

Contributions of authors

Olga Milena Garcia and Maria Ximena Rojas wrote the first draft of the protocol. Rodolfo Dennis commented on and contributed to the protocol and approved it before publication.

Sources of support

Internal sources

  • María Ximena Rojas and Rodolfo Dennis, Colombia.

    Department of Clinical Epidemiology and Biostatistics, Faculty of Medicine of the Pontificia Universidad Javeriana, supported the time dedicated by review authors.

External sources

  • No sources of support supplied

Declarations of interest

Over the past two years, RD has participated in advisory boards and in continued medical education activities sponsored by pharmaceutical industry entities interested in the treatment of patients with COPD, and has received payment for these activities.

OMG has no conflict of interest in the present review.

MXR has no conflict of interest in the present review.

Acknowledgements

Chris Cates served as the Editor and commented critically on this protocol.

The Background and Methods sections of this protocol are based on a standard template used by Cochrane Airways.

This project was supported by the National Institute for Health Research, via Cochrane Infrastructure funding to Cochrane Airways. The views and opinions expressed therein are those of the review authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS, or the Department of Health.

Professors Olga Milena García Morales, María Ximena Rojas‐ Reyes and Rodolfo J. Dennis thank professor Carlos Celis, who commented the background.

Version history

Published

Title

Stage

Authors

Version

2017 Aug 03

Oral xanthine derivatives (theophylline and doxofylline) for patients with stable chronic obstructive pulmonary disease (COPD)

Protocol

Olga M García Morales, Maria Ximena Rojas‐Reyes, Rodolfo J Dennis

https://doi.org/10.1002/14651858.CD012748

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.